PerkinElmer

Newborn Screening

OF

Use the highest quality reagents available today to screen for core newborn disorders as well as those detected by expanded screening. Our reagents are the industry standard for analytical performance and reliability in detecting congenital diseases that are treatable only when identified during the first days of life.

Products & Services (49)
Filters:
Application
  • Newborn Screening (4)
Product Brand Name
  • GSP® (16)
  • MSMS Kit (2)
  • NeoBase™ (5)
  • NeoLSD™ (2)
Detection Method
  • DELFIA (13)
  • Enzymatic (7)
Sample Type
  • Dried blood spots (8)
Assay Points (200-50,000)
  • 500 (1)
Automation Compatible
  • Yes (1)
Disorders
  • Biotinidase (BTD) Deficiency (4)
  • Congenital Adrenal Hyperplasia (CAH) (3)
  • Congenital Hypothyroidism (8)
  • Cystic Fibrosis (5)
  • Duchenne Muscular Dystrophy (1)
  • Fabry (2)
  • Galactosemia (7)
  • Gaucher (2)
  • Glucose-6-phosphate Dehydrogenase (G6PD) Deficiency (1)
  • Hemoglobinopathies (4)
  • Krabbe (2)
  • Metabolic Disorders (6)
  • MPS-I (2)
  • Niemann-Pick A/B (2)
  • Phenylketonuria (2)
  • Pompe (2)
  • SCID (3)
Format
  • Microplates (1)
Technology Type
  • MSMS (2)

Sort by

1-25 of 49 Products & Services

  • DX-Newborn-screening-kits_320px

    Neonatal Total Galactose kit (10 plate)

    Neonatal Total Galactose kit is intended for the quantitative determination of total galactose (galactose and galactose-1-phosphate) concentrations in blood specimens dried on filter paper as an aid in screening newborns for galactosemia.
  • DX-Newborn-screening-kits_320px

    NeoBase Non-derivatized Assay Solutions

    The NeoBase MSMS kit is intended for the quantitative determination of up to 11 clinically significant amino acids and 31 clinically significant acylcarnitines, detecting more than 30 different metabolic diseases from a single dried blood spot sample using the MS/MS tandem mass spectrometer.
  • DX-Newborn-screening-kits_320px

    Neonatal GALT kit (50 plate)

    Neonatal Galactose Transferase (GALT) kits are intended for the semi-quantitative determination of galactose-1-phosphate uridyltransferase (GALT) activity in blood specimens collected onto filter paper, in screening newborns for galactosemia.
  • DX-Newborn-screening-kits_320px

    NeoBase Non-derivatized Assay Solutions

    The NeoBase Non-derivatized Assay Solutions are intended for in vitro diagnostic use with the NeoBase Non-derivatized MSMS Kit and the NeoBase Succinylacetone Solution. The product includes NeoBase Flow Solvent and NeoBase Extraction Solution.
  • GSP Biotinidase kit

    GSP® Neonatal Biotinidase kit

    The GSP Neonatal Biotinidase assay is intended for the quantitative determination of biotinidase activity in blood specimens dried on filter paper as an aid in screening newborns for biotinidase deficiency by using the GSP® instrument.
  • DX-Newborn-screening-kits_320px

    NeoGram Derivatized Assay Solutions

    The NeoGram Derivatized Assay Solutions are intended for in vitro diagnostic use with the NeoGram Amino Acids and Acylcarnitines (AAAC) Tandem Mass Spectrometry Kit. The product includes NeoGram AAAC Flow Solvent, NeoGram AAAC Extraction Solution, NeoGram AAAC Reconstitution Solution and 3.0 N HCL in n-butanol.
  • Newborn screening kit

    GSP® Neonatal 17á-OH-progesterone kit

    The GSP Neonatal 17α-OH-progesterone assay is intended for the quantitative determination of 17OHP in dried blood spot specimens as an aid in screening newborns for CAH.
  • 3045-0010 NeoBase™ 2 Non-derivatized Assay Solutions

    NeoBase™ 2 Non-derivatized Assay Solutions

    The NeoBase 2 Non-derivatized Assay Solutions are intended for in vitro diagnostic use with the NeoBase 2 Non-derivatized MSMS kit (3044-0010) to extract target analytes from blood samples dried on filter paper and to carry target analytes to the MSMS system.
  • DX-Newborn-screening-kits_320px

    GSP Neonatal IRT kit

    The diagnosis of cystic fibrosis is often based on the symptoms, which may cause considerable delays in the disease intervention, and evidence indicates that early attention may be important in determining the clinical outcome.
  • NeoLSD MSMS Kit

    NeoLSD MSMS Kit

    The NeoLSD MSMS Kit is intended for the quantitative measurement of the activity of the enzymes acid-β-glucocerebrosidase (ABG), acid-sphingomyelinase (ASM), acid α glucosidase (GAA), β galactocerebrosidase (GALC), α-galactosidase A (GLA) and α-L-iduronidase (IDUA) in dried blood spots (DBS) from newborn babies.
  • GSP Neonatal GALT kit

    GSP® Neonatal GALT kit

    The GSP Neonatal GALT assay is used as an aid in screening newborns for classic galactosemia caused by GALT deficiency using the GSP™ instrument.
  • DX-Newborn-screening-kits_320px

    DELFIA® Neonatal Thyroxine (T4) kit (10 plate)

    This kit is intended for the quantitative determination of human thyroxine (T4) in blood specimens dried on filter paper as an aid in screening newborns for congenital (neonatal) hypothyroidism.
  • EnLite 223

    EnLite Neonatal TREC kit, 4 x 96 reactions

    The PerkinElmer EnLite Neonatal TREC kit, 4 x 96 reactions is an in vitro diagnostic product used with the VICTOR EnLite instrument for the semi-quantitative determination of TREC (T-cell receptor excision circle) DNA in blood specimens dried on filter paper.
  • DX-Newborn-screening-kits_320px

    GSP Neonatal Phenylalanine kit

    Phenylketonuria (PKU) is a disorder of amino acid metabolism with reported incidence ranging from 1 in 19,000 to 1 in 13,500 newborn infants*. It is caused by an inability to convert phenylalanine to tyrosine due to deficient activity of the enzyme, phenylalanine hydroxylase.
  • GSP Neonatal Thyroxine T4 kit

    GSP® Neonatal Thyroxine (T4) kit

    The PerkinElmer GSP Neonatal Thyroxine (T4) assay is used with dried blood spot specimens as an aid in screening newborns for congenital hypothyroidism.
  • PerkinElmer

    Neonatal Biotinidase kit (10 plate)

    Neonatal Biotinidase kit is intended for the semi-quantitative determination of biotinidase activity in blood specimens dried on filter paper as an aid in screening newborns for biotinidase deficiency.
  • DX-Newborn-screening-kits_320px

    DELFIA® Neonatal hTSH kit (10 plate)

    DELFIA Neonatal hTSH kits are intended for the quantitative determination of human thyroid stimulating hormone (hTSH) in blood specimens dried on filter paper as an aid in screening newborns for congenital hypothyroidism.
  • PerkinElmer

    RESOLVE Hemoglobin kit (3600 tests)

    The RESOLVE Neonatal Hemoglobin test kit is designed to separate whole blood, cord blood or dried blood spot specimens for detection of normal and variant hemoglobins by isoelectric focusing.
  • PerkinElmer
  • DX-Newborn-screening-kits_320px

    AutoDELFIA Neonatal hTSH kit (12 plate)

    This kit is intended for the quantitative determination of human thyroid stimulating hormone (hTSH) in blood specimens dried on filter paper as an aid in screening newborns for congenital (neonatal) hypothyroidism using the 1235 AutoDELFIA® automatic immunoassay system.
  • GSP Total Galactose TGAL kit tumma

    GSP® Neonatal Total Galactose kit

    The GSP Neonatal Total Galactose (TGAL) assay is intended for the quantitative determination of both galactose and galactose-1-phosphate in blood specimens dried on filter paper. The assay is used with the GSP® instrument as an aid in screening for deficiency in any of the three enzymes involved in galactose metabolism.
  • PerkinElmer

    RESOLVE Hemoglobin kit (360 tests)

    The RESOLVE Neonatal Hemoglobin test kit is designed to separate whole blood, cord blood or dried blood spot specimens for detection of normal and variant hemoglobins by isoelectric focusing.
  • DX-Newborn-screening-kits_320px

    GSP Neonatal Thyroxine (T4) kit

    Congenital hypothyroidism (CH) results from a failure of the thyroid glands to produce thyroid hormones in adequate amounts. The condition can easily be treated with daily doses of thyroid hormones but clinical diagnosis is difficult to establish and the disease may continue unrecognized for a long time causing irreversible brain damage.
  • GSP Neonatal IRT kit

    GSP® Neonatal IRT kit

    The GSP Neonatal IRT assay allows the quantitative determination of IRT from dried blood spot specimens, and is intended as an aid in screening for cystic fibrosis.
  • 3311-0010 GSP Creatine Kinease MM kit

    GSP Neonatal Creatine Kinase -MM kit

    The GSP Neonatal Creatine Kinase –MM kit is a solid phase, two-site fluoroimmunometric assay based on the direct sandwich technique. Analyte is bound to monoclonal CK-MM specific antibodies. The fluorescence signal is proportional to the analyte concentration in the sample.
  • Jump to: